Researchers at the University of California, Irvine injected older mice with a specific polyunsaturated fatty acid and observed improved visual performance, suggesting a potential path to reverse age-related vision decline.
The study, published in Science Translational Medicine, builds on earlier work linking the ELOVL2 gene to retinal health. When ELOVL2 activity declines with age, levels of very-long-chain polyunsaturated fatty acids (VLC-PUFAs) in the retina drop, impairing vision and increasing the risk of age-related macular degeneration. The team found that direct supplementation with a particular fatty acid — not docosahexaenoic acid (DHA) — restored visual function in aged mice without relying on the ELOVL2 enzyme.
Why this fatty acid works when DHA does not
The researchers tested multiple compounds and found that only one specific polyunsaturated fatty acid improved visual outcomes in older mice. DHA, despite being abundant in the retina and widely studied for eye health, did not produce the same effect. This indicates that the therapeutic benefit depends on the precise chemical structure of the supplemented fatty acid, not just general omega-3 intake.
How this builds on prior aging research
Earlier studies had shown that boosting ELOVL2 activity increased DHA and improved vision in mice, but the new approach bypasses the need for genetic or enzymatic intervention. Last time a similar strategy was attempted — using gene therapy to elevate ELOVL2 in retinal cells — results were inconsistent across models, highlighting the appeal of a direct biochemical workaround.
What is the fatty acid used in the study?
The source does not specify the exact name of the polyunsaturated fatty acid injected into the mice, only that We see not DHA and is effective in restoring visual function in aged animals.
Could this lead to a treatment for humans?
The researchers describe the findings as a proof-of-concept for lipid injection as a possible therapy, but human trials have not yet been conducted and are not mentioned in the source.
